Open AccessNSAID intolerance: it is not always what it seems
Author(s) -
Petkovic Tatjana Pecaric,
Pichler Werner J,
Hausmann Oliver
Publication year - 2014
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-4-s3-p7
Subject(s) - medicine , mefenamic acid , pantoprazole , provocation test , allergy , sensitization , anaphylaxis , dermatology , diclofenac , diphenhydramine , gastroenterology , anesthesia , histamine , pharmacology , immunology , alternative medicine , pathology , omeprazole
Case A: 42 year old female patient without asthma or polyposis nasi presented with palmar and plantar pruritus, urticaria, facial angioedema and dyspnea on two occasions: 2 and 4 hours after the intake of two structurally independent NSAIDs (diclofenac 75 mg, mefenamic acid 500 mg). In both instances, pantoprazole, a proton pump inhibitor (PPI), was prescribed for gastric protection. A non-allergic NSAID intolerance was suspected and avoidance of all classical cyclooxygenase (COX)-1 inhibitors recommended. Regardless, the patient's husband insisted on further allergological work-up remembering one unproblematic intake of mefenamic acid (500 mg) between the two events. Surprisingly, scratch testing was positive for pantoprazole only. This rare sensitization could be confirmed in basophil activation test (BAT). On further questioning the patient remembered that she forgot to take her pantoprazole co-medication when she transiently tolerated the mefenamic acid. The patient refused a provocation test with an alternative PPI. Due to their close structural relationship avoidance of all PPI was recommended. No general restriction for NSAIDs was necessary, and mefenamic acid was tolerated again. For long-term non-irritating anti-inflammatory pain treatment a COX-2 inhibitor (etoricoxib 30 mg) was advocated and well-tolerated.